Peritoneal dialysis of APP/PS1 mice (once a day for one month) was found to attenuate AD pathology, including tau hyperphosphorylation, glial activation, neuroinflammation, neuronal loss, and synaptic dysfunction [127]. Here, MAPT is linked to Alzheimer disease.